RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $40.3b | $286.50 | 0.0% | 187 |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $12.6b | $78.07 | 0.0% | 69 |
 ARWR | Arrowhead Research Corporation | $11.0b | $79.54 | 0.0% | 5.0K |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.3b | $5.79 | 0.0% | 2.4K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $228.0m | $3.98 | 0.0% | 2 |
 RNA | Atrium Therapeutics, Inc. Common Stock | $222.4m | $12.73 | 0.0% | 22 |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $221.5m | $8.88 | 0.0% | 3 |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $166.5m | $1.51 | 0.0% | 5.7K |
 XCUR | Exicure, Inc. Common Stock | $20.3m | $2.61 | 0.0% | 12.5K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $12.9m | $0.99 | 0.0% | 4.7K |